Alexandre Kaoukhov Selected Research

gallium arsenide (GaAs)

6/2017	Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
8/2016	Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
5/2016	Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alexandre Kaoukhov Research Topics

Disease

8	Acne Vulgaris 09/2018 - 01/2009
2	Vulvovaginal Candidiasis 09/2018 - 03/2018
2	Vertigo (Positional Vertigo) 09/2018 - 03/2018
2	Erythema 10/2016 - 05/2016
1	Atopic Dermatitis (Atopic Eczema) 10/2023
1	Dizziness (Lightheadedness) 09/2018
1	Infections 09/2018
1	Nasopharyngitis 09/2018
1	Nausea 09/2018
1	Sunburn 09/2018
1	Headache (Headaches) 09/2018
1	Tinnitus 09/2018
1	Vomiting 09/2018

Drug/Important Bio-Agent (IBA)

5	Dapsone FDA Link 06/2017 - 05/2016
3	gallium arsenide (GaAs)IBA 06/2017 - 05/2016
2	sarecyclineIBA 09/2018 - 03/2018
2	Tetracycline (Achromycin)FDA LinkGeneric 09/2018 - 03/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2018 - 03/2018
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	Immunoglobulin A (IgA)IBA 09/2018
1	TetracyclinesIBA 03/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2009
1	Adapalene (Differin)FDA LinkGeneric 01/2009